Astrid Borkowski - 21 Jun 2023 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Chief Medical Officer
Signature
/s/ Paul Bavier, Attorney-in-Fact for Astrid Borkowski
Issuer symbol
HLVX
Transactions as of
21 Jun 2023
Net transactions value
-$161,100
Form type
4
Filing time
23 Jun 2023, 10:09:21 UTC
Previous filing
03 Feb 2023
Next filing
13 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLVX Common Stock Disposed to Issuer $161,100 -10,000 -4.5% $16.11 210,193 21 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 434 shares acquired under the HilleVax, Inc. employee stock purchase plan on May 15, 2022, and 326 shares acquired (previously incorrectly reported as 341 shares acquired) under the HilleVax, Inc. employee stock purchase plan on November 15, 2022.